logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10314809 B1

PDFFull Text
Date of Patent:
Jun. 11, 2019

Filed:

Jul. 08, 2015

Application of derivative of clostridium ghonii

Applicant:

Shandong Xinchuang Biotechnology Co., Ltd., Jinan, CN;

Inventors:

Laitian Xing, Jinan, CN;

Yong Wang, Jinan, CN;

Mingqian Wei, Jinan, CN;

Yanqiu Xing, Jinan, CN;

Lianlian Li, Jinan, CN;

Lichao Xing, Jinan, CN;

Guangxia Deng, Jinan, CN;

Hong Meng, Jinan, CN;

Tao Huang, Jinan, CN;

Dongxia Yang, Jinan, CN;

Assignee:

SHANDONG XINCHUANG BIOTECHNOLOGY CO., LTD., Jinan, CN;

Attorney:

CBM Patent Consulting, LLC

Primary Examiner:

Vera Afremova

Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 35/742 (2015.01); A61K 9/19 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/337 (2013.01); A61K 9/19 (2013.01); A61K 35/742 (2013.01); A61P 35/00 (2018.01);
Abstract

Application of Derivatives of, especially in the application of Derivatives ofMW-DCG-HNCv-18 in preparation of medicines for treating non-small cell lung carcinoma. It also discloses a medicine combining the Derivatives ofMW-DCG-HNCv-18 strain with Docetaxel as the active ingredients. According to the invention, the MW-DCG-HNCv-18 strain is found to have specific inhibition effect on non-small cell lung carcinoma for the first time, the inhibition effect on the non-small cell lung carcinoma is significantly superior to that of other known similar strains, and through screening, the MW-DCG-HNCv-18 strain is found to have more prominent inhibition effect on non-small cell lung carcinoma when combined with Docetaxel injection.

Find Patent Forward Citations

Xing, Laitian. (2019). Application of derivative of clostridium ghonii (U.S. Patent No. 10314809). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10314809

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…